Mind Medicine New Zealand Film Screening – Trip of Compassion: A Window into Psychedelic-Assisted Psychotherapy · Mind Medicine Australia
Mind Medicine Australia logo Menu

Mind Medicine New Zealand Film Screening – Trip of Compassion: A Window into Psychedelic-Assisted Psychotherapy

With Tania de Jong AM and Melissa Warner

Date: Tue 27 July 2021 @ 6:30pm
Location: XCHC (Exchange Christchurch) | Creative Workspace, Cafe, and Events 376 Wilsons Road, Waltham, Christchurch 8011, New Zealand

Mind Medicine Australia’s New Zealand Chapter is thrilled to welcome you to the exclusive screening of Trip of Compassion, an acclaimed Israeli documentary on MDMA-assisted psychotherapy for the treatment of Post-Traumatic Stress Disorder (PTSD). Trip of Compassion follows a number of patients participating in clinical trials in Israel, and is the first feature documentary to show footage from within psychedelic-assisted therapy sessions.

  • Date: Tuesday 27 July
  • Venue: Christchurch Exchange, 376 Wilsons Road, Waltham, Christchurch https://www.xchc.co.nz/
  • Time: Doors open 6pm
  • Formalities commence: 6.30pm
  • Movie Commences: 6.45pm
  • Panel of Experts: 8pm

Light refreshments will be provided

Please note that content may disturb some viewers.

“I felt like I went through 15 years of psychological therapy in one night.”
–  Patient featured in Trip of Compassion

Watch the trailer here: 

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

The Presenters

Tania de Jong AM

LL.B (Hons), GradDipMus

Co-founder Mind Medicine Australia, Founder Creative Universe, Creativity Australia, The Song Room & Creative Innovation Global

Tania de Jong AM is a trail-blazing Australian soprano, award-winning social entrepreneur, creative innovation catalyst, spiritual journey woman, storyteller and global speaker. Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 3 charities including Creative Universe, Creativity Australia and With One Voice, Creative Innovation Global, Mind Medicine Australia, Dimension5, MTA Entertainment & Events, Pot-Pourri and The Song Room.

She works across the public, private, creative and community sectors and is passionate about mental health, innovation, diversity and inclusion.  Tania speaks and sings around the world as a soloist and with her group Pot-Pourri releasing twelve albums. She is Founder and Executive Producer of future-shaping events series, Creative Innovation Global and is now producing the Global Summit on Psychedelic Medicines for Mental Health.

She was appointed a Member of the Order of Australia in June 2008. Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally in 2021. Tania’s TED Talk ‘How Singing Together Changes The Brain’ has sparked international interest. Tania’s mission is to change the world, one voice at a time!

Melissa Warner

B.Science (Neuroscience), Grad Dip (Psych)

Melissa is an advocate for innovative solutions for mental health and is on a mission to cultivate an evidence and experience-based understanding of consciousness.  Melissa is Secretary of Psychedelic Research in Science and Medicine, Education and Communications Fellow at Mind Medicine Australia, co- founder of The Australian Psychedelic Society and a member of the UK-Australian Young Leaders Forum. After graduating in Neuroscience from the University of Melbourne, Melissa travelled to leading international centres of psychedelic research, transformative technology, meditation and somatic practices to forecast next-generation mental health treatments.  Currently, Melissa supports Australian psychedelic research trials at PRISM, the translation of clinical findings for advocacy and clinical training at Mind Medicine Australia and is a post-graduate psychology student at The University of Melbourne.

Melissa is an experienced meditation guide, having studied under Mingyur Rinpoche of the Mahamudra lineage. She is passionate about the potential of mindfulness-based approaches to scaffold and accentuate psychedelic healing.

As a preparation and integration coach, Melissa’s values the multiplicity of every individual and welcomes the whole person into every session. Melissa’s approach is informed by a scientific outlook, a transpersonal perspective, a positive psychology lens and grounded in somatic awareness.

Melissa seeks to create a space that nurtures the therapeutic, poetic, and eudaemonic capacities of the psyche.

In her creative time, Melissa enjoys her yoga practice, poetry, dance and painting.

Disclaimer: Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example Facebook, Instagram or Zoom private and public chat forms during a webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia:

It's time. Make your voice heard. Lodge a submission to the TGA supporting rescheduling of MDMA and Psilocybin. Closes May 27.